Your browser doesn't support javascript.
loading
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
Vokó, Zoltán; Kiss, Zoltán; Surján, György; Surján, Orsolya; Barcza, Zsófia; Wittmann, István; Molnár, Gergo Attila; Nagy, Dávid; Müller, Veronika; Bogos, Krisztina; Nagy, Péter; Kenessey, István; Wéber, András; Polivka, Lorinc; Pálosi, Mihály; Szlávik, János; Rokszin, György; Müller, Cecília; Szekanecz, Zoltán; Kásler, Miklós.
  • Vokó Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
  • Kiss Z; Syreon Research Institute, Budapest, Hungary.
  • Surján G; Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary.
  • Surján O; Ministry of Human Resources, Budapest, Hungary.
  • Barcza Z; Institute of Digital Health Sciences, Semmelweis University, Budapest, Hungary.
  • Wittmann I; Department of Deputy Chief Medical Officer II., National Public Health Center, Budapest, Hungary.
  • Molnár GA; Syntesia Medical Communications Ltd., Budapest, Hungary.
  • Nagy D; Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary.
  • Müller V; Second Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Hungary.
  • Bogos K; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
  • Nagy P; Syreon Research Institute, Budapest, Hungary.
  • Kenessey I; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Wéber A; Department of Pulmonology, National Korányi Institute of Pulmonology, Budapest, Hungary.
  • Polivka L; Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
  • Pálosi M; Department of Anatomy and Histology, Laboratory of Redox Biology, University of Veterinary Medicine, Budapest, Hungary.
  • Szlávik J; Institute of Oncochemistry, University of Debrecen, Debrecen, Hungary.
  • Rokszin G; Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
  • Müller C; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
  • Szekanecz Z; Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
  • Kásler M; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Front Immunol ; 13: 919408, 2022.
Article en En | MEDLINE | ID: mdl-35935993
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Humans / Infant / Middle aged País como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Humans / Infant / Middle aged País como asunto: Europa Idioma: En Año: 2022 Tipo del documento: Article